![Himanshu Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Himanshu Shah
Vorsitzender bei
EMEREN GROUP LTD
Vermögen: 3 Mio $ am 31.07.2026
Profil
Himanshu Harshad Shah is the founder of Shah Capital Management, Inc., founded in 2005, where the title held is President & Chief Investment Officer.
Mr. Shah is also the founder of Marius Pharmaceuticals LLC..
Mr. Shah currently holds the position of Chairman at Emeren Group Ltd. since 2022 and Managing General Partner at Shah Capital Opportunity Fund LP since 2016.
Former positions include Chairman at UTStarcom Holdings Corp.
from 2014 to 2019, Independent Director at Vitamin Shoppe, Inc. from 2018 to 2019, Director at UTStarcom, Inc. from 2013 to 2014, and Vice President at UBS Financial Services, Inc. Education includes an MBA from the University of Akron and an undergraduate degree from Gujarat University, conferred in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
China Yuchai International Ltd.
 China Yuchai International Ltd. Auto Parts: OEMProducer Manufacturing Operates as a holding company with interest in manufacture and distribution of diesel engines & provides hospitality and property development services 0.09% | 30.09.2025 | 34’417 ( 0.09% ) | 2 Mio $ | 31.07.2026 |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines 0.08% | 14.05.2026 | 126’295 ( 0.08% ) | 924 479 $ | 31.07.2026 |
Aktive Positionen von Himanshu Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| EMEREN GROUP LTD | Vorsitzender | 22.11.2022 |
Shah Capital Management, Inc.
 Shah Capital Management, Inc. Investment ManagersFinance Shah Capital is a global, sector agnostic manager that employs contrarian investment philosophy with an emphasis on turnarounds and special situations. | Vorstandsvorsitzender | 01.01.2005 |
Shah Capital Opportunity Fund LP
 Shah Capital Opportunity Fund LP Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 01.07.2016 |
Marius Pharmaceuticals LLC
 Marius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapies for testosterone deficiency | Gründer | - |
Ehemalige bekannte Positionen von Himanshu Shah
| Unternehmen | Position | Ende |
|---|---|---|
| VITAMIN SHOPPE, INC. | Direktor/Vorstandsmitglied | 16.12.2019 |
| UTSTARCOM HOLDINGS CORP. | Vorsitzender | 05.09.2019 |
UBS Financial Services, Inc.
 UBS Financial Services, Inc. Investment ManagersFinance UBS Financial Services' asset allocations are based on a proprietary methodology. In developing those allocations, the firm considers asset class risk and return results that are based on estimated forward-looking return and risk assumptions, as measured by standard deviation, which are based on UBS proprietary research. The development process includes a review of a variety of factors, including the return, risk, correlations and historical performance of various asset classes, inflation and risk premium. | Corporate Officer/Principal | 31.12.2004 |
UTStarcom, Inc.
 UTStarcom, Inc. Computer CommunicationsElectronic Technology Manufactures telecommunication devices | Vorsitzender | - |
Ausbildung von Himanshu Shah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
56
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
UBS Financial Services, Inc.
UBS Financial Services, Inc. Investment ManagersFinance UBS Financial Services' asset allocations are based on a proprietary methodology. In developing those allocations, the firm considers asset class risk and return results that are based on estimated forward-looking return and risk assumptions, as measured by standard deviation, which are based on UBS proprietary research. The development process includes a review of a variety of factors, including the return, risk, correlations and historical performance of various asset classes, inflation and risk premium. | Finance |
Vitamin Shoppe, Inc.
 Vitamin Shoppe, Inc. Food RetailRetail Trade Retails vitamins, minerals and herbs | Retail Trade |
UTStarcom, Inc.
UTStarcom, Inc. Computer CommunicationsElectronic Technology Manufactures telecommunication devices | Electronic Technology |
Emeren Group Ltd.
 Emeren Group Ltd. Engineering & ConstructionIndustrial Services Provides solar power project development, engineering, procurement and construction & electricity generation services | Industrial Services |
Shah Capital Opportunity Fund LP
Shah Capital Opportunity Fund LP Financial ConglomeratesFinance Provides investment services | Finance |
UTStarcom Holdings Corp.
 UTStarcom Holdings Corp. Telecommunications EquipmentElectronic Technology Provides communications equipment and services | Electronic Technology |
University of Akron
 University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gujarat University
 Gujarat University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shah Capital Management, Inc.
Shah Capital Management, Inc. Investment ManagersFinance Shah Capital is a global, sector agnostic manager that employs contrarian investment philosophy with an emphasis on turnarounds and special situations. | Finance |
Marius Pharmaceuticals LLC
Marius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapies for testosterone deficiency | Health Technology |
